NATALIE FARMER: Open Payments
NPI 1982244802 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 10 payments from 6 companies in 2025. Trend: 2023 $40 · 2024 $402 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $109 |
| GENZYME CORPORATION | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Grifols USA, LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $16 |
Products named: AIRSUPRA, DUPIXENT, TEZSPIRE, Rhapsido, Xembify, CUVITRU, FASENRA, Xolair.
Industry payments across CO — which companies pay providers there.
